XAIR Logo

Beyond Air, Inc. (XAIR) 

NASDAQ
Market Cap
$33.94M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
62 of 776
Rank in Industry
2 of 100

Largest Insider Buys in Sector

XAIR Stock Price History Chart

XAIR Stock Performance

About Beyond Air, Inc.

Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous …

Insider Activity of Beyond Air, Inc.

Over the last 12 months, insiders at Beyond Air, Inc. have bought $3.71M and sold $59,029 worth of Beyond Air, Inc. stock.

On average, over the past 5 years, insiders at Beyond Air, Inc. have bought $2.66M and sold $912,995 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Carey Robert (director) — $2.75M. Lisi Steven A. (CEO and Chairman of the Board) — $928,439. Lucera Erick (director) — $31,130.

The last purchase of 1,476,626 shares for transaction amount of $744,662 was made by Lisi Steven A. (CEO and Chairman of the Board) on 2024‑09‑26.

List of Insider Buy and Sell Transactions, Beyond Air, Inc.

2024-09-26PurchaseCEO and Chairman of the Board
1.48M
4.2606%
$0.50$744,6620.00%
2024-09-26Purchasedirector
1.48M
4.2606%
$0.50$744,6620.00%
2024-08-15PurchaseCEO and Chairman of the Board
50,000
0.09%
$0.37$18,3400.00%
2024-08-14Purchasedirector
100,000
0.1947%
$0.40$39,6800.00%
2024-08-14PurchaseCEO and Chairman of the Board
100,000
0.1896%
$0.39$38,6400.00%
2024-08-14Purchasedirector
39,266
0.0764%
$0.40$15,5650.00%
2023-12-28SaleChief Business Officer
25,000
0.0789%
$2.06$51,451-38.73%
2023-12-27SaleChief Medical Officer
3,423
0.0107%
$2.21$7,579-43.82%
2023-12-18Purchasedirector
1.2M
3.6746%
$1.64$1.96M-25.30%
2023-12-18PurchaseCEO and Chairman of the Board
77,775
0.2375%
$1.63$126,797-25.30%
2023-11-16PurchaseChief Operating Officer
10,000
0.0353%
$1.77$17,700-17.46%
2023-08-28Purchasedirector
250,000
0.7698%
$2.69$673,750-41.67%
2023-08-21Purchasedirector
75,050
0.236%
$2.76$207,453-40.94%
2023-08-18Purchasedirector
13,614
0.0424%
$2.64$35,940-38.53%
2023-06-30PurchaseChief Operating Officer
5,000
0.0177%
$4.51$22,550-58.80%
2023-03-31Purchasedirector
5,000
0.0165%
$6.67$33,350-64.00%
2023-03-30Purchasedirector
10,000
0.0329%
$6.45$64,500-62.96%
2023-03-29Purchasedirector
10,000
0.0328%
$6.30$63,000-61.86%
2023-03-28Purchasedirector
3,115
0.0105%
$6.34$19,749-60.80%
2023-03-24PurchaseChief Operating Officer
1,000
0.0033%
$6.15$6,150-58.14%

Insider Historical Profitability

<0.0001%
Lisi Steven A.CEO and Chairman of the Board
3249411
4.5013%
$0.47214+11.3%
Carey Robertdirector
1476626
2.0455%
$0.47320<0.0001%
Gaul Michael A.Chief Operating Officer
88150
0.1221%
$0.4750<0.0001%
Lucera Erickdirector
43608
0.0604%
$0.4720<0.0001%
Avniel AmirChief Business Officer
0
0%
$0.47325+4.4%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Aigh Capital Management Llc$6.46M8.093.71MNew+$6.46M3.7
BlackRock$3.14M3.941.81M-2.72%-$87,816.06<0.0001
The Vanguard Group$2.43M3.051.4M+4.97%+$115,229.78<0.0001
Kingdon Capital Management$2.36M2.961.36M-0.4%-$9,392.520.31
RTW Investments, LP$2.1M2.631.2MNew+$2.1M0.03
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.